Skip to content

Clinical trials

Mental Disorders trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Country / region: Czechia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20092
20131
20161
20202
20211
20223
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S2
Affiris AG1
AstraZeneca1
Charles University, Czech Republic1
Inmune Bio, Inc.1
MapLight Therapeutics1
Neurocrine Biosciences1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Semmelweis University1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders12
Alzheimer Disease4
Brain Diseases4
Dementia4
Nervous System Diseases4
Neurodegenerative Diseases4
Tauopathies4
Central Nervous System Diseases3
Major Depressive Disorder3
Alcohol-Related Disorders2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.